Status | Study |
Not yet recruiting |
Study Name: PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy Condition: Carcinoma, Basal Cell Date: 2017-04-24 Interventions: Drug: REGN2810 Regimen as per protocol |
Not yet recruiting |
Study Name: Neoadjuvant Vismodegib in Patients With Large and/or Recurrent Resectable Basal Cell Carcinoma Condition: Basal Cell Carcinoma Date: 2016-12-26 Interventions: Drug: Vismodegib 1 capsule (150 mg vismodegib) taken once daily for a maximum of 12 weeks. |
Completed |
Study Name: Study of Electronic Brachytherapy for Cutaneous Basal Cell Carcinoma Condition: Carcinoma, Basal Cell Date: 2016-10-13 Interventions: Device: Electronic Brachytherapy (6,1 Gy) |
Recruiting |
Study Name: To Assess The Efficacy And Safety Of Vismodegib And Radiotherapy In Advanced Basal Cell Carcinoma Condition: Carcinoma, Basal Cell Date: 2016-07-20 Interventions: Drug: Vismodegib Patients will |
Active, not recruiting |
Study Name: Assessment of the Clinic-pathological Correlation of Basal Cell Carcinoma Condition: Basal Cell Carcinoma Date: 2016-07-04 |
Recruiting |
Study Name: Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the Size of Sporadic Nodular Basal Cell Carcinomas Condition: Basal Cell Carcinomas Date: 2016-07-01 Interventions: Drug: patidegib gel 2% - cohort 1 |
Recruiting |
Study Name: Vismodegib on Locally Advanced and Metastatic Basal Cell Carcinoma Under Real World Conditions Condition: Metastatic Basal Cell Carcinoma Date: 2016-04-24 |
Recruiting |
Study Name: Topical Itraconazole in Treating Patients With Basal Cell Cancer Condition: Skin Basal Cell Carcinoma Date: 2016-03-31 Interventions: Drug: Itraconazole Applied top |
Not yet recruiting |
Study Name: Arsenic Trioxide and Itraconazole in Treating Patients With Advanced Basal Cell Cancer Condition: Skin Basal Cell Carcinoma Date: 2016-03-01 Interventions: Drug: Arsenic Trioxide Given P |
Recruiting |
Study Name: Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer Condition: Skin Basal Cell Carcinoma Date: 2016-02-12 Interventions: Other: Laboratory Biomarker Analysis |